| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.087 | 0.09 |